Advantages of human umbilical vein scaffolds derived from cesarean section vs. vaginal delivery for vascular tissue engineering

Biomaterials

Volumn 29, Issue 8, 2008, Pages 1075-1084

  Hoenicka, Markus ^a   Jacobs, Volker R ^b   Huber, Georgine ^c   Schmid, Franz Xaver ^a   Birnbaum, Dietrich E ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Arterial tissue engineering; MTT assay; Platelet adhesion; Thrombogenicity; Vascular grafts

Indexed keywords

POTASSIUM COMPOUNDS; STERILIZERS;

PLATELET ADHESION; THROMBOGENICITY; VASCULAR GRAFTS;

TISSUE ENGINEERING;

ANTICOAGULANT AGENT; HISTAMINE; POTASSIUM CHLORIDE; PROSTACYCLIN; SEROTONIN; TETRAZOLIUM;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; ISCHEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOCYTE ADHESION; TISSUE ENGINEERING; UMBILICAL CORD; UMBILICAL VEIN; VAGINAL DELIVERY; VASCULAR TISSUE; VASOCONSTRICTION;

ADULT; CESAREAN SECTION; EPOPROSTENOL; FEMALE; HISTAMINE; HUMANS; ISCHEMIA; MALE; MICROSCOPY, ELECTRON, SCANNING; NATURAL CHILDBIRTH; PLATELET ADHESIVENESS; POTASSIUM CHLORIDE; PREGNANCY; SEROTONIN; TETRAZOLIUM SALTS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; UMBILICAL VEINS; VASOCONSTRICTION; VASODILATION;

EID: 37349045115     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.11.010     Document Type: Article

References (40)

1. Bordenave L., Fernandez P., Rémy-Zolghadri M., Villars S., Daculsi R., and Midy D. In vitro endothelialized ePTFE prostheses: clinical update 20 years after the first realization. Clin Hemorheol Microcirc 33 3 (2005) 227-234
2. Salacinski H.J., Goldner S., Giudiceandrea A., Hamilton G., Seifalian A.M., Edwards A., et al. The mechanical behavior of vascular grafts: a review. J Biomater Appl 15 3 (2001) 241-278
3. Badylak S.F. The extracellular matrix as a biologic scaffold material. Biomaterials 28 25 (2007) 3587-3593
4. Hoenicka M., Lehle K., Jacobs V.R., and Schmid F.X. Birnbaum DE properties of the human umbilical vein as a living scaffold for a tissue-engineered vessel graft. Tissue Eng 13 1 (2007) 219-229
5. Jacobs V.R., Niemeyer M., Gottschalk N., Schneider K.T.M., Kiechle M., Oostendorp R.A.J., et al. Das STEMMAT-Projekt als Teil der Gesundheitsinitiative BayernAktiv: Adulte Stammzellen aus Nabelschnur und -blut als Alternative zur embryonalen Stammzellforschung. [The STEMMAT project as part of the health initiative BayernAktiv: adult stem cells from umbilical cord and cord blood as alternative to embryonic stem cell research.]. Zentralbl Gynakol 127 6 (2005) 368-372
6. Daniel J., Abe K., and McFetridge P.S. Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J 51 3 (2005) 252-261
7. Hoerstrup S.P., Zünd G., Sodian R., Schnell A.M., Grünenfelder J., and Turina M.I. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg 20 1 (2001) 164-169
8. Pence S., Kocoglu H., Balat O., and Balat A. The effect of delivery on umbilical arterial cord blood gases and lipid peroxides: comparison of vaginal delivery and cesarean section. Clin Exp Obstet Gynecol 29 3 (2002) 212-214
9. Rogers M.S., Mongelli J.M., Tsang K.H., Wang C.C., and Law K.P. Lipid peroxidation in cord blood at birth: the effect of labour. Br J Obstet Gynaecol 105 7 (1998) 739-744
10. Raijmakers M.T.M., Roes E.M., Steegers E.A.P., van der Wildt B., and Peters W.H.M. Umbilical glutathione levels are higher after vaginal birth than after cesarean section. J Perinat Med 31 6 (2003) 520-522
11. Miller N.M., Fisk N.M., Modi N., and Glover V. Stress responses at birth: determinants of cord arterial cortisol and links with cortisol response in infancy. BJOG 112 7 (2005) 921-926
12. Aisien A.O., Towobola O.A., Otubu J.A., and Imade G.E. Umbilical cord venous progesterone at term delivery in relation to mode of delivery. Int J Gynaecol Obstet 47 1 (1994) 27-31
13. Jouppila R., Puolakka J., Kauppila A., and Vuori J. Maternal and umbilical cord plasma noradrenaline concentrations during labour with and without segmental extradural analgesia, and during caesarean section. Br J Anaesth 56 3 (1984) 251-255
14. Boelsterl M. Der prädiktive Wert perinataler fetaler und maternaler Geburtsparameter für den relativen Gehalt mononukleärer und CD34-positiver Zellen im Nabelschnurblut Neugeborener. [The predictive value of perinatal fetal and maternal birth parameters for the concentration of mononuclear and CD34-positive cells in cord blood.] Thesis. Technische Universität München, Munich, 2007.
15. Li W., Huang T., Zeng Y., and Yao Z. The relationship between gestational age and compliance in human umbilical vein and its possible application in vascular grafting. Ann Vasc Surg 20 2 (2006) 237-242
16. Lehle K., Hoenicka M., Jacobs V.R., Schmid F.X., and Birnbaum D.E. Identification and reduction of cryoinjury in endothelial cells: a first step towards establishing a cell bank for vascular tissue engineering. Tissue Eng 12 12 (2006) 3439-3447
17. Goldkrand J.W., Schulte R.L., and Messer R.H. Maternal and fetal plasma cortisol levels at parturition. Obstet Gynecol 47 1 (1976) 41-45
18. Falconer A.D., and Poyser L.M. Fetal sympatho-adrenal mediated metabolic responses to parturition. Br J Obstet Gynaecol 93 7 (1986) 747-753
19. Facchinetti F., Lanzani A., and Genazzani A.R. Fetal intermediate lobe is stimulated by parturition. Am J Obstet Gynecol 161 5 (1989) 1267-1270
20. Irestedt L., Dahlin I., Hertzberg T., Sollevi A., and Lagercrantz H. Adenosine concentration in umbilical cord blood of newborn infants after vaginal delivery and cesarean section. Pediatr Res 26 2 (1989) 106-108
21. Bird J.A., Spencer J.A., Mould T., and Symonds M.E. Endocrine and metabolic adaptation following caesarean section or vaginal delivery. Arch Dis Child Fetal Neonatal Ed 74 2 (1996) F132-F134
22. Gitau R., Menson E., Pickles V., Fisk N.M., Glover V., and MacLachlan N. Umbilical cortisol levels as an indicator of the fetal stress response to assisted vaginal delivery. Eur J Obstet Gynecol Reprod Biol 98 1 (2001) 14-17
23. Marshall N.J., Goodwin C.J., and Holt S.J. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul 5 2 (1995) 69-84
24. Berridge M.V., and Herst P.M. Tan AS tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev (2005) 11127-11152
25. Pennati G. Biomechanical properties of the human umbilical cord. Biorheology 38 5-6 (2001) 355-366
26. Furchgott R.F., Cherry P.D., Zawadzki J.V., and Jothianandan D. Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol Suppl. 6 (1984) 2S336-2S343
27. Altura B.M., Malaviya D., Reich C.F., and Orkin L.R. Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol 222 2 (1972) 345-355
28. Quan A., Leung S.W.S., Lao T.T., and Man R.Y.K. 5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure. J Soc Gynecol Invest 10 8 (2003) 490-495
29. Rogines-Velo M.P., Pelorosso F.G., Zold C.L., Brodsky P.T., and Rothlin R.P. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 2. Evidence of involvement of 5-HT1B receptors using functional studies. Naunyn Schmiedebergs Arch Pharmacol 366 6 (2002) 596-604
30. Rogines-Velo M.P., Pelorosso F.G., Zold C.L., Nowak W., Pesce G.O., Sardi S.P., et al. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays. Naunyn Schmiedebergs Arch Pharmacol 366 6 (2002) 587-595
31. Karlsson C., Bodelsson G., Bodelsson M., and Stjernquist M. Characterization of 5-hydroxytryptamine receptors mediating circular smooth muscle contraction in the human umbilical artery. Gynecol Obstet Invest 47 2 (1999) 102-107
32. Fecteau K.A., and Eiler H. Placenta detachment: unexpected high concentrations of 5-hydroxytryptamine (serotonin) in fetal blood and its mitogenic effect on placental cells in bovine. Placenta 22 1 (2001) 103-110
33. Varela A.F., Runge A., Ignarro L.J., and Chaudhuri G. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults. Am J Obstet Gynecol 167 6 (1992) 1599-1604
34. Moncada S., and Vane J.R. The role of prostacyclin in vascular tissue. Fed Proc 38 1 (1979) 66-71
35. Klockenbusch W., Braun M.S., Schröder H., Heckenberger R.E., Strobach H., and Schrör K. Prostacyclin rather than nitric oxide lowers human umbilical artery tone in vitro. Eur J Obstet Gynecol Reprod Biol 47 2 (1992) 109-115
36. Cruz M.A., Gallardo V., Miguel P., Carrasco G., and González C. Mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contractions of human placental vein. Gen Pharmacol 30 4 (1998) 483-488
37. Williams K.I., and El Tahir K.E. Effects of uterine stimulant drugs on prostacyclin production by the pregnant rat myometrium. I. Oxytocin, bradykinin and PGF2 alpha. Prostaglandins 19 1 (1980) 31-38
38. Goyal A., Wang Y., Su H., Dobrucki L.W., Brennan M., Fong P., et al. Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. J Pediatr Surg 41 4 (2006) 787-791
39. Dardik H., Wengerter K., Qin F., Pangilinan A., Silvestri F., Wolodiger F., et al. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J Vasc Surg 35 1 (2002) 64-71
40. Lamm P., Juchem G., Milz S., Schuffenhauer M., and Reichart B. Autologous endothelialized vein allograft: a solution in the search for small-caliber grafts in coronary artery bypass graft operations. Circulation 104 12 Suppl. 1 (2001) I108-I114